Silke Haim

Sulfur [ ¹⁸ F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis

ESUR prostate MR guidelines 2012

Molecular imaging in drug development

Skeletal PET with¹⁸F-Fluoride: Applying New Technology to an Old Tracer

Imaging of prostate cancer local recurrences: why and how?

Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging

Cancer Imaging With Fluorine-18–Labeled Choline Derivatives

Matching chelators to radiometals for radiopharmaceuticals

The Emerging Hallmarks of Cancer Metabolism

Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer

Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)

Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates

The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications

Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology

Cancer de la prostate

Positron Emission Tomography/Computed Tomography with F-18-fluorocholine for Restaging of Prostate Cancer Patients: Meaningful at PSA < 5 ng/ml?

BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)